Clinical and Translational Radiation Oncology
短名 | Clin. Transl. Radiat. Oncol. |
Journal Impact | 2.52 |
国际分区 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING(Q2) |
期刊索引 | SCI Q2中科院 3 区 |
ISSN | 2405-6308 |
h-index | 31 |
国内分区 | 医学(3区)医学肿瘤学(3区)医学核医学(3区) |
涉及主题 | 医学内科学外科放射科生物放射治疗遗传学癌症病理肿瘤科核医学数学物理统计化学计算机科学心理学 |
出版信息 | 出版商: Elsevier Ireland Ltd,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2016,原创研究文献占比: 84.38%,自引率:3.70%, Gold OA占比: 78.93% |
平均审稿周期 | 网友分享经验:28 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study
2024-9-1
Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”
2024-9-1
CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience
2024-9-1
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020
2024-9-1
Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation
2024-9-1
Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors
2024-9-1
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning
2024-9-1
Radiation response assessment of organoids derived from patients with pancreatic cancer
2024-9-1
HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques
2024-9-1
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution
2024-9-1
Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)
2024-9-1
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy
2024-9-1
Temporary halo fixation and radiotherapy as alternative to long-construct spondylodesis in patients with multiple unstable cervical metastases
2024-9-1
Remineralization of lytic spinal metastases after radiation therapy – A retrospective cohort study comparing conventional external beam radiation therapy with stereotactic ablative body radiation
2024-9-1
Impact of discrimination on training and career of radiation oncologists in France
2024-9-1
Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study
2024-9-1
Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT
2024-9-1
Adaptive bridging radiation therapy for relapsed/refractory B-cell lymphoma patient undergoing CAR T-cell therapy: Case report
2024-9-1
Understanding the impact of radiation-induced lymphopenia: Preclinical and clinical research perspectives
2024-9-1
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study
2024-9-1
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center
2024-9-1
Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study
2024-9-1
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer
2024-9-1
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study
2024-9-1
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation
2024-9-1
Letter to the Editor
2024-9-1
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma
2024-9-1
Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC
2024-9-1
Exploring long-term outcomes following CyberKnife robotic radiosurgery for trigeminal neuralgia
2024-9-1
The time course of health-related Quality of Life in rectal cancer patients undergoing combined modality treatment
2024-9-1
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors
2024-9-1
Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy
2024-9-1
Selection for proton radiotherapy of grade 1–3 glioma patients
2024-9-1
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study
2024-9-1
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”
2024-9-1
CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy
2024-9-1
The carbon footprint of external beam radiotherapy and its impact in health technology assessment
2024-9-1
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer
2024-8-27
In response to Chuong et al.
2024-8-20
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice
2024-8-10
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era – A systematic review
2024-8-1
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy
2024-8-1
Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma
2024-8-1
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers
2024-8-1
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials
2024-8-1
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy
2024-7-30
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis
2024-7-7
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility
2024-7-3
Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial
2024-7-1
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma
2024-7-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远